FDA Clearance for Dexcom is a Major Step for CGM

by Jonathan Collins | 1Q 2017 | IN-4402

In a significant step forward for continuous glucose monitoring acceptance, Dexcom was awarded FDA clearance for its G5 continuous glucose monitor to inform users for treatment decisions—without the use of a confirmed reading from a finger-stick glucometer.

You must be a subscriber to view this Insight.

To find out more about subscribing:
Contact a representative about purchasing options.